PLAY PODCASTS
Ep. 31 Zero G, Crystals and Keytruda: Space MD Builds the New Frontier of Drug Design
Season 1 · Episode 31

Ep. 31 Zero G, Crystals and Keytruda: Space MD Builds the New Frontier of Drug Design

Spark Time!

November 7, 202556m 14s

Audio is streamed directly from the publisher (redirect.zencastr.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, we have a, high-energy conversation with Molly Mulligan and Ken Savin from Space MD about how space-made crystals are changing drug development on Earth. Their team grows protein crystals on the International Space Station because in zero gravity, the structures form more perfectly, revealing details that scientists can’t see on the ground. One of their first successes was Keytruda, where space-grown crystals helped refine molecular structures that shaped a blockbuster therapy. We also cover running experiments in orbit, scaling the model for everyday pharma, and what happens when microgravity becomes just another R&D tool. It’s biotech, but cosmic.

Topics

space-made crystalsmicrogravity drug developmentspace biotechprotein crystallization in spacezero gravity researchspace mddrug design in microgravityinternational space station researchspace-based r&dspace-grown protein crystalskeytruda crystal structuremolecular structure refinementspace-based drug discoverybiotech innovationpharmaceutical research in orbitcrystallography in zero gspace pharmaprotein structure analysiscrystal growth experiments issmolecular design from space